Saltar al contenido
Dispositivos y mediciónArtículo de investigación3 min read

Wearable use is lower in US adults with or at risk for heart disease

Colectivo editorial MoveVitals · Study published · Reading updated

Original paper:Use of Wearable Devices in Individuals With or at Risk for Cardiovascular Disease in the US, 2019 to 2020. · JAMA network open · 2023 · Artículo original ↗

Idea principal

In a nationally representative survey of 9303 US adults, an estimated 18% of those with cardiovascular disease (CVD) and 26% of those at risk used wearable devices, versus 29% of all adults. Among people at risk, older age, lower education and lower income were independently linked with lower use, but the data are self-reported and cross-sectional.

Study design

Artículo de investigación

Reading basis

Published abstract

Reading focus

Design & applicability

Esta explicación editorial está disponible en inglés, chino simplificado y chino tradicional. Esta interfaz muestra la lectura en inglés.

Pregunta de investigación

Wearables might improve cardiovascular health, but uneven uptake could widen health disparities. The authors described who uses wearables among US adults with or at risk for CVD, how often, and whether they would share the data with clinicians.

Población y método

Population-based cross-sectional study using the nationally representative Health Information National Trends Survey (HINTS), 2019 to 2020, analysed from June 1 to November 15, 2022. CVD was self-reported (history of heart attack, angina or congestive heart failure); being at risk meant at least 1 of hypertension, diabetes, obesity or cigarette smoking. Outcomes, all self-reported, were access to wearables, frequency of use and willingness to share health data with clinicians. Estimates were nationally weighted, and associations were adjusted for demographics, cardiovascular risk factors and socioeconomic features.

Resultados

The authors’ reported results. Read each estimate with its population and uncertainty.

  1. 1
    Of 9303 participants (representing 247.3 million US adults), 933 (10.0%) had CVD and 5185 (55.7%) were at risk for CVD.
  2. 2
    An estimated 3.6 million adults with CVD (18%; 95% CI 14%-23%) and 34.5 million at risk (26%; 95% CI 24%-28%) used wearables, compared with 29% (95% CI 27%-30%) of all US adults.
  3. 3
    Among those at risk, lower use was independently associated with older age (OR 0.35; 95% CI 0.26-0.48), lower educational attainment (OR 0.35; 95% CI 0.24-0.52) and lower household income (OR 0.42; 95% CI 0.29-0.60).
  4. 4
    Among users, 38% (95% CI 26%-50%) of adults with CVD used a wearable every day, versus 49% (95% CI 45%-53%) overall and 48% (95% CI 43%-53%) of the at-risk group. 83% (95% CI 70%-92%) of users with CVD and 81% (95% CI 76%-85%) of at-risk users favoured sharing data with clinicians.

Límites e incertidumbre

  1. 1
    All exposures and outcomes were self-reported, including CVD history and wearable use.
  2. 2
    Cross-sectional data capture use in 2019 to 2020 only, before later changes in device adoption, and cannot show why people do or do not use wearables.
  3. 3
    Only 933 participants had established CVD, so estimates for that group have wider confidence intervals (for example 18%, 95% CI 14%-23%).
  4. 4
    Willingness to share data was asked only of users; the abstract does not say whether they actually did, and this reading is based on the abstract only.

Relevancia práctica

The gap is largest among older adults and people with less education or income, who are often the people with the highest cardiovascular risk. If you help a relative choose a device, simplicity and cost may matter. The study does not show that wearables improve heart health.

Tus datos

Many users in this survey wore a device less than daily. For trends in resting heart rate, steps or sleep to be meaningful, wear the same device consistently and compare against your own baseline instead of other people's numbers.

Cómo interpretar la evidencia

The index does not establish a precise design. Read the methods before making causal claims; check population, comparator, outcomes and uncertainty in the source.

Resumen estructurado de los autores English

El resumen original en inglés se reproduce con atribución bajo la licencia indicada. Es una fuente, no una interpretación de MoveVitals. El análisis preparado figura arriba; verifica los resultados importantes en la fuente.

Importance

Wearable devices may be able to improve cardiovascular health, but the current adoption of these devices could be skewed in ways that could exacerbate disparities.

Objective

To assess sociodemographic patterns of use of wearable devices among adults with or at risk for cardiovascular disease (CVD) in the US population in 2019 to 2020.

Design, setting, and participants

This population-based cross-sectional study included a nationally representative sample of the US adults from the Health Information National Trends Survey (HINTS). Data were analyzed from June 1 to November 15, 2022.

Exposures

Self-reported CVD (history of heart attack, angina, or congestive heart failure) and CVD risk factors (≥1 risk factor among hypertension, diabetes, obesity, or cigarette smoking).

Main outcomes and measures

Self-reported access to wearable devices, frequency of use, and willingness to share health data with clinicians (referred to as health care providers in the survey).

Results

Of the overall 9303 HINTS participants representing 247.3 million US adults (mean [SD] age, 48.8 [17.9] years; 51% [95% CI, 49%-53%] women), 933 (10.0%) representing 20.3 million US adults had CVD (mean [SD] age, 62.2 [17.0] years; 43% [95% CI, 37%-49%] women), and 5185 (55.7%) representing 134.9 million US adults were at risk for CVD (mean [SD] age, 51.4 [16.9] years; 43% [95% CI, 37%-49%] women). In nationally weighted assessments, an estimated 3.6 million US adults with CVD (18% [95% CI, 14%-23%]) and 34.5 million at risk for CVD (26% [95% CI, 24%-28%]) used wearable devices compared with an estimated 29% (95% CI, 27%-30%) of the overall US adult population. After accounting for differences in demographic characteristics, cardiovascular risk factor profile, and socioeconomic features, older age (odds ratio [OR], 0.35 [95% CI, 0.26-0.48]), lower educational attainment (OR, 0.35 [95% CI, 0.24-0.52]), and lower household income (OR, 0.42 [95% CI, 0.29-0.60]) were independently associated with lower use of wearable devices in US adults at risk for CVD. Among wearable device users, a smaller proportion of adults with CVD reported using wearable devices every day (38% [95% CI, 26%-50%]) compared with overall (49% [95% CI, 45%-53%]) and at-risk (48% [95% CI, 43%-53%]) populations. Among wearable device users, an estimated 83% (95% CI, 70%-92%) of US adults with CVD and 81% (95% CI, 76%-85%) at risk for CVD favored sharing wearable device data with their clinicians to improve care.

Conclusions and relevance

Among individuals with or at risk for CVD, fewer than 1 in 4 use wearable devices, with only half of those reporting consistent daily use. As wearable devices emerge as tools that can improve cardiovascular health, the current use patterns could exacerbate disparities unless there are strategies to ensure equitable adoption.

Fuentes y atribución

Use of Wearable Devices in Individuals With or at Risk for Cardiovascular Disease in the US, 2019 to 2020.

Dhingra LS, Aminorroaya A, Oikonomou EK, Nargesi AA, Wilson FP, Krumholz HM, Khera R.

JAMA network open · 2023-06-01

DOI: 10.1001/jamanetworkopen.2023.16634 ↗PubMed · 37285157 ↗Europe PMC · Licencia registrada: cc by ↗

Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.

Interpretación editorial de MoveVitals · contenido educativo · sin revisión clínica individual registrada

Fuentes verificadas 2026-11-01

Guías prácticas

Leer en contexto

·Estudio de cohorte

Activity–stroke and heart attack curves differ by accelerometer processing method

Among 90,237 UK Biobank adults free of cardiovascular disease at baseline, followed until December 2022 for 1,298 strokes and 2,031 myocardial infarctions, the shape of the link between moderate-vigorous physical activity (MVPA) and each outcome depended on how the accelerometer data were processed. For stroke, hazard fell in a straight line only with the machine-learning metric; for myocardial infarction, two metrics gave a curved decline and activity counts a straight one. The abstract gives no hazard ratios, so it shows that methods disagree, not which one is right, and the findings are observational associations.

Preventive Medicine

Explicaciones detalladasLeer estudio →
·Estudio/revisión de validación

Smartwatch data as forensic evidence: heart rate is best validated, the rest uneven

A systematic review and meta-analysis of studies on smartwatches from four major brands, framed around digital forensics, found that heart rate was both the most studied and the most accurate measure. Step count, distance, energy expenditure, activity classification and sleep were less consistently validated, and results varied by brand, protocol and reporting. The abstract gives no pooled numbers, and most studies were run in healthy people in laboratories, so it cannot say how a particular watch performs for a particular person in daily life.

Forensic Science International

Explicaciones detalladasLeer estudio →
·Revisión de revisiones

Activity trackers: about 1,800 more steps a day, but small effects on other outcomes

An umbrella review of 39 systematic reviews and meta-analyses, covering 163,992 participants, found that activity trackers were associated with more physical activity (SMD 0.3–0.6), equating to about 1,800 extra steps and 40 minutes more walking per day, and with a bodyweight reduction of about 1 kg. Effects on blood pressure, cholesterol, glycosylated haemoglobin, quality of life and pain were typically small and often non-significant. The abstract does not say what else came with the trackers in these programs or how much the reviews overlap, so the gains cannot be credited to the device alone.

The Lancet Digital Health

Explicaciones detalladasLeer estudio →
·Estudio/revisión de validación

Seven sleep trackers: good at spotting sleep, weak on wake and sleep stages

In a sleep laboratory, 34 healthy young adults wore a subset of seven consumer sleep trackers for three nights. Against polysomnography every device detected sleep very well (sensitivity 0.93 or higher) but caught wake poorly (specificity 0.18–0.54), and five of the seven matched or beat research actigraphy (specificity 0.39). Sleep-stage estimates were inconsistent, and the participants were healthy adults aged 18 to 35 in a fixed 8-hour bed window, with each device tested in only 11 to 20 of them, so the results say little about people with sleep problems.

Sleep

Explicaciones detalladasLeer estudio →
Dispositivos y medición →